Literature DB >> 30904813

Nitrogen-containing derivatives of O-tetramethylquercetin: Synthesis and biological profiles in prostate cancer cell models.

Pravien Rajaram1, Ziran Jiang1, Guanglin Chen1, Alyssa Rivera1, Alison Phasakda1, Qiang Zhang2, Shilong Zheng2, Guangdi Wang2, Qiao-Hong Chen3.   

Abstract

Forty-eight nitrogen-containing quercetin derivatives were synthesized from readily available rutin or quercetin for the in vitro evaluation of their biological profiles. The WST-1 cell proliferation assay data indicate that thirty-nine out of the forty-eight derivatives possess significantly improved antiproliferative potency as compared with quercetin and fisetin, as well as the parent 3,3',4',7-O-tetramethylquercetin toward both androgen-sensitive (LNCaP) and androgen-insensitive (PC-3 and DU145) human prostate cancer cell lines. 5-O-Aminoalkyl-3,3',4',7-O-tetramethylquercetins were established as a better scaffold for further development as anti-prostate cancer agents. Among them, 5-O-(N,N-dibutylamino)propyl-3,3',4',7-O-tetramethylquercetin (44) was identified as the optimal derivative with IC50 values of 0.55-2.82 µM, being over 35-182 times more potent than quercetin. The flow cytometry-based assays further demonstrate that 44 effectively activates PC-3 cell apoptosis.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antiproliferative activity; Cell apoptosis; Prostate cancer; Quercetin derivative; Synthesis

Year:  2019        PMID: 30904813      PMCID: PMC6538460          DOI: 10.1016/j.bioorg.2019.03.047

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  30 in total

1.  Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden).

Authors:  Maria Hedelin; Asa Klint; Ellen T Chang; Rino Bellocco; Jan-Erik Johansson; Swen-Olof Andersson; Satu-Maarit Heinonen; Herman Adlercreutz; Hans-Olov Adami; Henrik Grönberg; Katarina Augustsson Bälter
Journal:  Cancer Causes Control       Date:  2006-03       Impact factor: 2.506

2.  Quercetin-induced growth inhibition and cell death in prostatic carcinoma cells (PC-3) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression.

Authors:  M R Vijayababu; P Kanagaraj; A Arunkumar; R Ilangovan; M M Aruldhas; J Arunakaran
Journal:  J Cancer Res Clin Oncol       Date:  2005-11-01       Impact factor: 4.553

3.  Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in western New York.

Authors:  Susan E McCann; Christine B Ambrosone; Kirsten B Moysich; John Brasure; James R Marshall; Jo L Freudenheim; Gregg S Wilkinson; Saxon Graham
Journal:  Nutr Cancer       Date:  2005       Impact factor: 2.900

4.  Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial.

Authors:  D A Shoskes; S I Zeitlin; A Shahed; J Rajfer
Journal:  Urology       Date:  1999-12       Impact factor: 2.649

5.  Phytoestrogens in common herbs regulate prostate cancer cell growth in vitro.

Authors:  Nader S Shenouda; Christine Zhou; Jimmy D Browning; Pete J Ansell; Mary S Sakla; Dennis B Lubahn; Ruth S Macdonald
Journal:  Nutr Cancer       Date:  2004       Impact factor: 2.900

6.  Flavonoids and prostate cancer risk: a study in Italy.

Authors:  Cristina Bosetti; Francesca Bravi; Renato Talamini; Maria Parpinel; Patrizia Gnagnarella; Eva Negri; Maurizio Montella; Pagona Lagiou; Silvia Franceschi; Carlo La Vecchia
Journal:  Nutr Cancer       Date:  2006       Impact factor: 2.900

7.  Antiproliferative activities of citrus flavonoids against six human cancer cell lines.

Authors:  John A Manthey; Najla Guthrie
Journal:  J Agric Food Chem       Date:  2002-10-09       Impact factor: 5.279

8.  Flavonol and flavone intakes in US health professionals.

Authors:  Laura Sampson; Eric Rimm; Peter C H Hollman; Jeanne H M de Vries; Martijn B Katan
Journal:  J Am Diet Assoc       Date:  2002-10

9.  The dietary bioflavonoid, quercetin, selectively induces apoptosis of prostate cancer cells by down-regulating the expression of heat shock protein 90.

Authors:  Ravikumar Aalinkeel; B Bindukumar; Jessica L Reynolds; Donald E Sykes; Supriya D Mahajan; Kailash C Chadha; Stanley A Schwartz
Journal:  Prostate       Date:  2008-12-01       Impact factor: 4.104

10.  Evaluation of the potential in vivo genotoxicity of quercetin.

Authors:  D Utesch; K Feige; J Dasenbrock; T H Broschard; M Harwood; B Danielewska-Nikiel; T C Lines
Journal:  Mutat Res       Date:  2008-05-02       Impact factor: 2.433

View more
  1 in total

1.  Kaempferol, Myricetin and Fisetin in Prostate and Bladder Cancer: A Systematic Review of the Literature.

Authors:  Felice Crocetto; Erika di Zazzo; Carlo Buonerba; Achille Aveta; Savio Domenico Pandolfo; Biagio Barone; Francesco Trama; Vincenzo Francesco Caputo; Luca Scafuri; Matteo Ferro; Vincenzo Cosimato; Ferdinando Fusco; Ciro Imbimbo; Giuseppe Di Lorenzo
Journal:  Nutrients       Date:  2021-10-23       Impact factor: 5.717

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.